U.S. market Closed. Opens in 1 day 20 hours 2 minutes

BHVN | Biohaven Pharmaceutical Holding Company Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312017-12-31
RevenueN/AN/A462.51MN/AN/AN/A
Cost of Revenue3.37M1.39M91.66M72.00KN/AN/A
Gross Profit-3.37M-1.39M370.85M-72.00KN/AN/A
Operating Expenses436.05M567.93M218.90M114.51M479.12MN/A
Selling, General & Admin62.77M130.86M37.41M16.05M134.45MN/A
Research & Development373.28M437.07M181.49M98.46M344.67MN/A
Other Operating ExpensesN/A-1.91M1.21MN/AN/AN/A
Operating Income-436.05M-567.93M-218.90M-114.51M-479.12MN/A
Other Expenses / Income26.50M-1.91M6.47M-4.16M-49.26MN/A
Before Tax Income-409.55M-569.84M-212.43M-118.67M-528.39MN/A
Income Tax Expenses-1.38M438.00K1.37M-134.30K419.00KN/A
Net Income-408.17M-570.28M-213.80M-118.67M-528.80MN/A
Interest ExpensesN/AN/AN/AN/A-12.71MN/A
Basic Shares Outstanding71.20M44.74M35.82M35.82M48.49MN/A
Diluted Shares Outstanding71.20M44.74M35.82M35.82M48.49MN/A
EBITDA-429.14M-462.80M-217.51M-114.43M-479.12MN/A
EBITDA Margin0.00%0.00%-47.03%0.00%0.00%0.00%
EBIT-409.55M-569.84M-212.43M-118.80M-541.10MN/A
EBIT Margin0.00%0.00%-45.93%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙